Medication Safety and Pharmacovigilance in Clinical: From the Researcher Bench to the Patient Bedside...

— —

Alfredo Vannacci Niccol� Lombardi

Medication Safety and Pharmacovigilance in Clinical

From the Researcher Bench to the Patient Bedside

Alfredo Vannacci, Niccol� Lombardi, Giada Crescioli

$200.95 $170.47

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Mdpi AG
27 March 2024

Pharmacology

Summary
Details

Recent years, particularly the COVID-19 pandemic, can be considered a turning point for pharmacovigilance and pharmacoepidemiology in terms of their role in drug safety and drug utilization monitoring in clinical practice. In this context, researchers operating in the fields of pharmacovigilance and pharmacoepidemiology have extensive knowledge about approved medications, many of which have been or are currently undergoing clinical trials for repurposing. Among them, clinical pharmacologists' knowledge can be used and translated to optimize dosing and treatment regimens and to assess the relationship between drug exposure and adverse drug events, with the crucial aims of optimizing drugs' efficacy and ensuring drug safety in a real-world setting. Real-world data are crucial to further establish the safety profile of pharmacological treatments. As a next step, real-world data from electronic health databases may be used in pharmacovigilance and pharmacoepidemiology to monitor drug utilization patterns, as well as the efficacy and safety of drugs in large populations. Furthermore, this approach will be particularly useful for the monitoring of COVID-19 vaccines' efficacy and safety. In this reprint, experts submited population-based studies (cohort or case-control studies), drug utilization studies, systematic reviews and meta-analyses, and review articles that contribute to improving the understanding of the role of pharmacovigilance and pharmacoepidemiology before, during, and after the COVID-19 pandemic.

Guest editor: Alfredo Vannacci, Niccol� Lombardi, Giada Crescioli
Imprint: Mdpi AG
Dimensions: Height: 244mm, Width: 170mm, Spine: 18mm
Weight: 617g
ISBN: 9783725806812
ISBN 10: 3725806810
Pages: 192
Publication Date: 27 March 2024
Audience: General/trade , ELT Advanced
Format: Hardback
Publisher's Status: Active

AUSTRALIA-WIDE LOW FLAT RATE $9.90

Medication Safety and Pharmacovigilance in Clinical

From the Researcher Bench to the Patient Bedside

Alfredo Vannacci, Niccol� Lombardi, Giada Crescioli

$200.95 $170.47

Hardback

See Also

Contact Abbeys

Contact Galaxy

Contact Language

Contact Us

About ABBEY'S